Reverse transcriptase inhibitors (RTIs)
|
|
(1) Nucleoside and nucleotide analog reverse transcriptase inhibitors (NRTIs) |
|
Abacavir (Ziagen) |
|
Abacavir + lamivudine + zidovudine (Trizivir) |
|
Abacavir + lamivudine (Epzicom/Kivexa) |
|
Didanosine (Videx, Videx EC) |
|
Emtricitabine (Emtriva) |
|
Lamivudine (Epivir) |
|
Lamivudine + zidovudine (Combivir) |
|
Stavudine (Zerit) |
|
Tenofovir (Viread) |
|
Zalcitabine (Hivid) |
|
Zidovudine (Retrovir) |
|
(2) Nonnucleoside reverse transcriptase inhibitors (NNRTIs) |
|
Delavirdine (Rescriptor) |
|
Efavirenz (Sustiva, Stocrin, Efavir) |
|
Efavirenz + tenofovir + emtricitabine (Atripla) |
|
Etravirine (Intelence) |
|
Nevirapine (Viramune) |
|
Rilpivirine (Edurant) |
|
Rilpivirine + tenofovir + emtricitabine (Complera) |
|
|
Protease inhibitors (PIs)
|
|
Amprenavir (Agenerase) |
|
Atazanavir (Reyataz) |
|
Darunavir (Prezista) |
|
Fosamprenavir (Lexiva, Telzir) |
|
Indinavir (Crixivan) |
|
Lopinavir (Kaletra) |
|
Nelfinavir (Viracept) |
|
Ritonavir (Norvir) |
|
Saquinavir (Fortovase, Invirase) |
|
Tipranavir (Aptivus) |
|
|
Integrase inhibitors
|
|
Raltegravir (Isentress) |
|
|
Entry inhibitors
|
|
Maraviroc (Selzentry) |
|
Enfuvirtide (Fuzeon) |
|